JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB188029

Anti-MIRO1 antibody [CL1083]

4

(4 Reviews)

|

(15 Publications)

Anti-MIRO1 antibody [CL1083] (ab188029) is a mouse monoclonal antibody detecting MIRO1 in Western Blot, IHC-P. Suitable for Human.

- KO validated for confirmed specificity

View Alternative Names

ARHT1, RHOT1, Mitochondrial Rho GTPase 1, MIRO-1, hMiro-1, Rac-GTP-binding protein-like protein, Ras homolog gene family member T1

9 Images
Western blot - Anti-MIRO1 antibody [CL1083] (AB188029)
  • WB

Lab

Western blot - Anti-MIRO1 antibody [CL1083] (AB188029)

False colour image of Western blot : Anti-MIRO1 antibody [CL1083] staining at 1/500 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab188029 was shown to bind specifically to MIRO1. A band was observed at 71 kDa in wild-type HeLa cell lysates with no signal observed at this size in RHOT1 knockout cell line ab265792 (knockout cell lysate ab258635). To generate this image, wild-type and RHOT1 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.

All lanes:

Western blot - Anti-MIRO1 antibody [CL1083] (ab188029) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 40 µg

Lane 2:

RHOT1 knockout HeLa cell lysate at 40 µg

Lane 2:

Western blot - Human RHOT1 (MIRO1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-rhot1-miro1-knockout-hela-cell-line-ab265792'>ab265792</a>)

Lane 3:

HEK-293 cell lysate at 20 µg

Lane 4:

A431 cell lysate at 20 µg

Predicted band size: 71 kDa

Observed band size: 71 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human liver tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human small intestine tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human cerebral cortex tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human testis tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human stomach cancer tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MIRO1 antibody [CL1083] (AB188029)

Immunohistochemical analysis of paraffin-embedded Human cerebellum tissue, labeling MIRO1 using ab188029 at a 1/200 dilution.

Western blot - Anti-MIRO1 antibody [CL1083] (AB188029)
  • WB

Supplier Data

Western blot - Anti-MIRO1 antibody [CL1083] (AB188029)

All lanes:

Western blot - Anti-MIRO1 antibody [CL1083] (ab188029) at 1/500 dilution

All lanes:

Human cerebral cortex tissue

Predicted band size: 71 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CL1083

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

Recombinant Fragment Protein within Human RHOT1 aa 50-150. The exact immunogen used to generate this antibody is proprietary information.

Q8IXI2

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-MIRO1 antibody [CL1083] (ab188029) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of MIRO1?
Anti-MIRO1 [CL1083] (ab188029) specifically detects a band for MIRO1 (UniProt: Q8IXI2) at a molecular weight of 71kDa.

Specificity confirmed
The specificity of Anti-MIRO1 antibody [CL1083] (ab188029) has been confirmed by Western blot testing in RHOT1 Knockout HeLa cell line, ab265792.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MIRO1 also known as RhoT1 is a mitochondrial Rho GTPase with a molecular mass of approximately 69 kDa. It functions as a pivotal component in mitochondrial transport and dynamics. This protein localizes to the outer mitochondrial membrane and is highly expressed in various tissues particularly in the brain and muscles. MIRO1 facilitates the anchoring of mitochondria to microtubule motors enabling their movement within the cell which is essential for maintaining proper energy distribution.
Biological function summary

MIRO1 plays a significant role in regulating mitochondrial trafficking along the cytoskeleton. It forms part of a protein complex with TRAK1/2 kinesin and dynein motor proteins. MIRO1's presence in this complex allows it to modulate mitochondrial distribution and dynamics which are essential for neural development and function. It also influences mitochondrial shape and interaction with the endoplasmic reticulum impacting intracellular calcium homeostasis.

Pathways

MIRO1 is an integral component of pathways involving mitochondrial transport and cellular energy homeostasis. It actively participates in the regulation of calcium signaling pathways alongside related proteins like TRAK1. Additionally MIRO1's involvement in the maintenance of mitochondrial dynamics links it to mitophagy pathways. These pathways regulate the removal of damaged mitochondria a vital process for cellular health and longevity.

MIRO1 has connections to neurodegenerative conditions such as Parkinson's disease and Alzheimer's disease. These conditions correlate with impaired mitochondrial trafficking and dynamics. MIRO1 interacts with proteins such as PINK1 and Parkin which contribute to mitochondrial quality control and are involved in the pathogenesis of these diseases. The disruption of MIRO1 function can lead to mitochondrial dysfunction and energy deficits which are underlying factors in these neurodegenerative processes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mitochondrial GTPase involved in mitochondrial trafficking (PubMed : 12482879, PubMed : 16630562, PubMed : 22396657). Probably involved in control of anterograde transport of mitochondria and their subcellular distribution (PubMed : 12482879, PubMed : 16630562, PubMed : 22396657). Promotes mitochondrial fission during high calcium conditions (PubMed : 27716788).
See full target information RHOT1

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine (Cambridge, Mass.) 31:307 PubMed41023810

2025

EPO-modified bone marrow MSCs alleviate asthma inflammation through enhanced mitochondrial activation and transfer by upregulating HO-1.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Zhang,Li-Zhan Chen,Hai-Feng Ou-Yang

Science advances 11:eadu5091 PubMed40203102

2025

ARMC1 partitions between distinct complexes and assembles MIRO with MTFR to control mitochondrial distribution.

Applications

Unspecified application

Species

Unspecified reactive species

Michael J McKenna,Felix Kraus,João P L Coelho,Muskaan Vasandani,Jiuchun Zhang,Benjamin M Adams,Joao A Paulo,J Wade Harper,Sichen Shao

Frontiers in oncology 15:1543657 PubMed40196735

2025

RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70.

Applications

Unspecified application

Species

Unspecified reactive species

Maxim Shevtsov,Natalia Yudintceva,Danila Bobkov,Ruslana Likhomanova,Anastasiya Nechaeva,Elena Mikhailova,Elena Oganesyan,Viacheslav Fedorov,Andrey Kurkin,Anastasiya Lukacheva,Georgii Fofanov,Aleksander Kim,Evegeniy Fedorov,Daria Sitovskaya,Alexey Ulitin,Natalia Mikhailova,Ilya Anufriev,Maria Istomina,Ekaterina Murashko,Elizaveta Kessenikh,Nikolay Aksenov,Yulia Vakhitova,Konstantin Samochernykh,Emil Pitkin,Evgeny Shlyakhto,Stephanie E Combs

Clinical science (London, England : 1979) 138:1537-1559 PubMed39535903

2024

Protective effect of mesenchymal stromal cells in diabetic nephropathy: the In vitro and In vivo role of the M-Sec-tunneling nanotubes.

Applications

Unspecified application

Species

Unspecified reactive species

Federica Barutta,Beatrice Corbetta,Stefania Bellini,Roberto Gambino,Stefania Bruno,Shunsuke Kimura,Koji Hase,Hiroshi Ohno,Gabriella Gruden

iScience 27:109994 PubMed38883841

2024

MFN2 coordinates mitochondria motility with α-tubulin acetylation and this regulation is disrupted in CMT2A.

Applications

Unspecified application

Species

Unspecified reactive species

Atul Kumar,Delfina Larrea,Maria Elena Pero,Paola Infante,Marilisa Conenna,Grace J Shin,Vincent Van Elias,Wesley B Grueber,Lucia Di Marcotullio,Estela Area-Gomez,Francesca Bartolini

Nature communications 15:4757 PubMed38834564

2024

Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Lan Ma,Chun-Yan Kong,Zhen Guo,Ming-Yu Wang,Pan Wang,Fang-Yuan Liu,Dan Yang,Zheng Yang,Qi-Zhu Tang

Nature communications 14:8040 PubMed38086799

2023

Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes.

Applications

Unspecified application

Species

Unspecified reactive species

Tina Rönn,Jones K Ofori,Alexander Perfilyev,Alexander Hamilton,Karolina Pircs,Fabian Eichelmann,Sonia Garcia-Calzon,Alexandros Karagiannopoulos,Hans Stenlund,Anna Wendt,Petr Volkov,Matthias B Schulze,Hindrik Mulder,Lena Eliasson,Sabrina Ruhrmann,Karl Bacos,Charlotte Ling

Communications biology 6:420 PubMed37061660

2023

Vimar/RAP1GDS1 promotes acceleration of brain aging after flies and mice reach middle age.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Xiong,Qi Cheng,Yajie Li,Yanping Han,Xin Sun,Lei Liu

Acta neuropathologica communications 10:78 PubMed35606853

2022

Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.

Applications

Unspecified application

Species

Unspecified reactive species

Rose B Creed,Adeel A Memon,Sindhu P Komaragiri,Sandeep K Barodia,Matthew S Goldberg

Renal failure 44:304-313 PubMed35333675

2022

Anti-phospholipase A2 receptor antibodies directly induced podocyte damage .

Applications

Unspecified application

Species

Unspecified reactive species

Yanfen Li,Juntao Yu,Miao Wang,Zhao Cui,Ming-Hui Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com